Literature DB >> 7443602

Jaundice associated with naproxen.

R M Victorino, J C Silveira, A Baptista, M C de Moura.   

Abstract

Hepatic injury in association with naproxen therapy is described and documented by liver biopsy in one patient. Histological findings were consistent with a drug-induced hepatitis, and cessation of therapy led to reversal of the clinical and biochemical changes. Circumstantial evidence is in favour of a hypersensitivity response to the drug rather than direct hepatotoxicity. Increased awareness of clinicians of this probably rare side effect of naproxen may help prompt identification of similar cases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7443602      PMCID: PMC2425629          DOI: 10.1136/pgmj.56.655.368

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Jaundice associated with naproxen.

Authors:  I P Law; H Knight
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

2.  Pharmacokinetics of naproxen overdoses.

Authors:  R Runkel; M D Chaplin; H Sevelius; E Ortega; E Segre
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

3.  [Clinical trial with naproxen, with particular consideration to tolerance].

Authors:  W Frenger; H J Morbach
Journal:  Scand J Rheumatol Suppl       Date:  1973

4.  Letter: Jaundice associated with naproxen.

Authors:  B H Bass
Journal:  Lancet       Date:  1974-05-18       Impact factor: 79.321

5.  Naproxen overdose.

Authors:  E W Fredell; L J Strand
Journal:  JAMA       Date:  1977-08-29       Impact factor: 56.272

  5 in total
  11 in total

1.  Simultaneous voltammetric determination of acetaminophen, naproxen, and theophylline using an in-situ polymerized poly(acrylic acid) nanogel covalently grafted onto a carbon black/La2O3 composite.

Authors:  Bhuvanenthiran Mutharani; Palraj Ranganathan; Shen-Ming Chen; Chelladurai Karuppiah
Journal:  Mikrochim Acta       Date:  2019-08-28       Impact factor: 5.833

Review 2.  Effects of non-narcotic analgesics on the liver.

Authors:  L F Prescott
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 3.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

4.  Cross hepatotoxicity between non-steroidal anti-inflammatory drugs.

Authors:  M Andrejak; T Davion; J L Gineston; J P Capron
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

Review 5.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 6.  Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.

Authors:  A V Manoukian; J L Carson
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 7.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

8.  Diclofenac-induced hepatotoxicity.

Authors:  D Schapira; L Bassan; A M Nahir; Y Scharf
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

Review 9.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 10.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.